# Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010)

> **NCT01002924** · PHASE2 · COMPLETED · sponsor: **Endocyte** · enrollment: 1 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** EC145

## Key facts

- **NCT ID:** NCT01002924
- **Lead sponsor:** Endocyte
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12-31
- **Primary completion:** 2013-12-11
- **Final completion:** 2013-12-11
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2021-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002924, "Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01002924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*